EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Omics Integration Identifies G6PD as a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Suggests Its Immunoregulatory Role

Yinhai Wang, Miao Tian, Wenyi Zhuang, Yue Hu, Xiping Yu, Xiaokang Jia, Aimin Gong

International Journal of Molecular Sciences · 19.11.2026 · 27 (22) · 10393

DOI: 10.3390/ijms272210393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.11.2026. Verfasst von Yinhai Wang und 6 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China Youth Program, Hainan Provincial Natural Science Foundation Youth Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) has an insidious onset and poor prognosis, and the limited diagnostic accuracy of alpha-fetoprotein necessitates novel biomarkers. This study aims to construct an analytical framework for integrating multi-omics data from tumor tissues and single-cell transcriptomes. By integrating and analyzing the transcriptomic and clinical data of HCC, we confirmed that glucose-6-phosphate dehydrogenase (G6PD) is significantly upregulated in tumor tissues and consistently overexpressed across multiple independent cohorts, with a diagnostic area under the curve of 0.906. High G6PD expression was associated with shorter overall survival and remained an independent adverse prognostic factor. To explore the potential mechanism, a virtual knockout of G6PD was simulated on single-cell transcriptomic data, which indicated that G6PD knockout significantly perturbs immune-related pathways, including antigen processing and presentation and phagocytosis. These findings not only highlight the potential of G6PD as a candidate diagnostic and prognostic biomarker for HCC but also suggest its involvement in the tumor immune microenvironment, offering new directions for further research on the diagnosis and treatment of HCC.

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of China Youth Program
  • Hainan Provincial Natural Science Foundation Youth Program
  • Education Department of Hainan Province
  • Hainan Medical University 2025 Academic Enhancement Support Program
  • Hainan Medical University 2025 Undergraduate Research Innovation Training Program

Zitieren

APA

Wang, Y., Tian, M., Zhuang, W., Hu, Y., Yu, X., Jia, X., & Gong, A. (2026). Multi-Omics Integration Identifies G6PD as a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Suggests Its Immunoregulatory Role. International Journal of Molecular Sciences, 27(22), 10393. https://doi.org/10.3390/ijms272210393

Vancouver

Wang Y, Tian M, Zhuang W, Hu Y, Yu X, Jia X, et al. Multi-Omics Integration Identifies G6PD as a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Suggests Its Immunoregulatory Role. International Journal of Molecular Sciences. 2026;27(22):10393. doi:10.3390/ijms272210393

BibTeX
@article{Wang2026,
  author = {Wang, Yinhai and Tian, Miao and Zhuang, Wenyi and Hu, Yue and Yu, Xiping and Jia, Xiaokang and Gong, Aimin},
  title = {Multi-Omics Integration Identifies G6PD as a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Suggests Its Immunoregulatory Role},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10393},
  doi = {10.3390/ijms272210393}
}
Kostenlos starten →